Lass(o)man back at it
Novatis and Incyte on the back foot again
New substantial data
49% 4 year survival
Assays. Reasonable
Jakafi...horrible stuff and they know it
Rem-L.... incredible stuff and they know it
Billions on the line
Brian says Krause is livid
ODAC 9 - 1 in favour
Unmet need
Randomized trial for kids? Nah can't be done
Full approval with adult trial or AA with P4? Sounds fair
Parents of kids with GVHD say yes.
Place your bets....will it be the Food & Drug Administration or the Fraud Department of America again??
Lass(o)man back at itNovatis and Incyte on the back foot...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.015(1.40%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.12 | $1.08 | $11.51M | 10.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17804 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 230637 | 5 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.015 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.12 | $1.08 | 1937390 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| MSB (ASX) Chart |